Search

Your search keyword '"Parissis, John T."' showing total 485 results
Start Over Author "Parissis, John T."
485 results on '"Parissis, John T."'

1. Implementation of a cardiogenic shock team in a tertiary academic center

Author

Karamasis, Grigoris V., Polyzogopoulou, Effie, Varlamos, Charalampos, Frantzeskaki, Frantzeska, Dragona, Vassiliki-Maria, Boultadakis, Antonios, Bistola, Vasiliki, Fountoulaki, Katerina, Pappas, Christos, Kolokathis, Fotios, Pavlopoulos, Dionysios, Toumpoulis, Ioannis K., Kollias, Vasilios D., Farmakis, Dimitrios, Rallidis, Loukianos S., Angouras, Dimitrios C., Tsangaris, Iraklis, Parissis, John T., and Filippatos, Gerasimos

Published
2024
Full Text
View/download PDF

2. Prevalence of Transthyretin Amyloid Cardiomyopathy Among Acute Heart Failure Patients with Hypertrophy Across the Left Ventricular Ejection Fraction Spectrum.

Author

Velliou, Maria, Markos, Lampros, Qiuris, Stella, Bezati, Sofia, Ventoulis, Ioannis, Matsiras, Dionysis, Bistola, Vasiliki, Ikonomidis, Ignatios, Polyzogopoulou, Effie, and Parissis, John T.

Subjects
LEFT ventricular hypertrophy, HEART failure patients, VENTRICULAR ejection fraction, PEPTIDES, HEART failure
Abstract

Background/Objectives: Transthyretin amyloid (ATTR) cardiomyopathy mimics left ventricular hypertrophy (LVH) and has been identified as a specific cause of heart failure (HF). The aim of this study was to assess the prevalence of ATTR among patients presenting to the Emergency Department (ED) with acute HF (AHF) and LVH and explore their clinical characteristics and outcomes. Methods: Of 127 AHF patients with LVH, 95 completed the diagnostic protocol, which included monoclonal paraprotein testing and technetium-99 m pyrophosphate scintigraphy. Patients were followed for 6 months, and adverse events, including mortality and HF-related hospitalizations, were recorded. Results: ATTR was diagnosed in 8.4% of patients. The mean left ventricular ejection fraction (EF) was 46 ± 7% in ATTR subjects, with 25% classified as HF with reduced EF, 37.5% HF with mildly reduced EF, and 37.5% HF with preserved EF. N-terminal pro b-type natriuretic peptide (NT-proBNP) and high sensitivity troponin T (hs-TnT) were higher in ATTR compared to the non-ATTR group [NT-proBNP: 5863 (6519–12382) pg/mL versus 3586 (1393.5–6322) pg/mL, p = 0.007; hs-TnT: 35.9 (47.9–83.8) pg/mL versus 30.0 (19.4–49.5) pg/mL, p = 0.0006]. During follow-up, twenty-three patients from the cohort died: six in the ATTR and seventeen in the non-ATTR group. The estimated survival rate was significantly lower in ATTR versus non-ATTR patients (log-rank p < 0.0001). Conclusions: In this cohort of AHF patients with LVH presenting to the ED, ATTR cardiomyopathy was detected in 8.4%. Using routinely used cardiac biomarkers and basic echocardiography allows for the raising of suspicion of the disease from the ED setting, potentially facilitating earlier diagnosis in this population. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

3. Predictive Value of N-Terminal Pro B-Type Natriuretic Peptide for Short-Term Outcome of Cardioversion in Patients with First-Diagnosed or Paroxysmal Atrial Fibrillation Presenting to the Emergency Department.

Author

Diakantonis, Antonios, Verras, Christos, Bezati, Sofia, Bistola, Vasiliki, Ventoulis, Ioannis, Velliou, Maria, Boultadakis, Antonios, Ikonomidis, Ignatios, Parissis, John T., and Polyzogopoulou, Effie

Subjects
ELECTRIC countershock, ATRIAL fibrillation, PEPTIDES, ARRHYTHMIA, HOSPITAL emergency services, ELECTRONOGRAPHY
Abstract

Background: Atrial fibrillation (AF) is a common arrhythmia in the emergency department (ED). We investigated the role of N-terminal pro b-type natriuretic peptide (NT-proBNP) in predicting both the outcome of AF cardioversion and the risk of AF recurrence or persistence on the 8th (D8) and 30th (D30) day post-cardioversion. Methods: This prospective, observational study evaluated patients with recent-onset AF, managed by either pharmacological (PC) or electrical cardioversion (EC) in the ED. Patients were treated either immediately or electively after 3 weeks of anticoagulation. NT-proBNP assessments were performed prior to cardioversion. Results: Of the 148 patients enrolled, 56% had paroxysmal AF, 85% underwent immediate cardioversion and 72% received EC. Successful cardioversion to sinus rhythm (SR) was achieved in 85% of patients. Patients with successful cardioversion and those who remained free from AF on D8 had lower NT-proBNP levels compared to patients with failed cardioversion or with AF recurrence or persistence on D8 [day of cardioversion, D0: SR vs. non-SR, 387 (127–1095) pg/mL vs. 1262 (595–2295), p = 0.004; D8: SR vs. non-SR, 370 (127–1095) vs. 1366 (718–2295), p = 0.002]. In multivariate analysis, higher logNT-proBNP was associated with higher risk of cardioversion failure [OR, 95%CI: 4.80 (1.58–14.55), p = 0.006] and AF recurrence or persistence on D8 [OR, 95%CI: 3.65 (1.06–12.59), p = 0.041]. ROC analysis confirmed the predictive ability of NT-proBNP for both outcomes (D0: AUC 0.735, p < 0.001; D8: AUC 0.761, p < 0.001). A cut-off value of NT-proBNP > 580 pg/mL was able to predict failure of AF conversion and occurrence of recurrent/persistent AF at D8. Conclusions: NT-proBNP is a promising biomarker for identifying patients presenting to the ED with recent-onset AF who run a greater risk of cardioversion failure and post-discharge AF recurrence/persistence in the immediate and short term. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

5. Acute Heart Failure

Author

Harjola, Veli-Pekka, Bueno, Héctor, Parissis, John T., Dorobanţu, Maria, editor, Ruschitzka, Frank, editor, and Metra, Marco, editor

Published
2016
Full Text
View/download PDF

8. Exercise Testing in Coronary Heart Disease

Author

Adamopoulos, Stamatis, Fountoulaki, Katerina, Parissis, John T., Perk, Joep, editor, Gohlke, Helmut, editor, Hellemans, Irene, editor, Sellier, Philippe, editor, Mathes, Peter, editor, Monpère, Catherine, editor, McGee, Hannah, editor, and Saner, Hugo, editor

Published
2007
Full Text
View/download PDF

9. Optimal use of intravenous landiolol in acute cardiac care.

Author

Bezati, Sofia, Boultadakis, Antonios, Ventoulis, Ioannis, Polyzogopoulou, Eftihia, and Parissis, John T.

Subjects
VENTRICULAR tachycardia, HEART diseases, MYOCARDIAL infarction, CARDIAC patients, MEDICAL research, CARDIAC intensive care
Abstract

B-blockers are regarded as beneficial pharmacologic agents in cardiac care, but their role in the acute setting remains ambiguous. Increasing evidence supports the important role of landiolol in critical care, a highly cardioselective intravenous b-blocker with rapid onset of action and short elimination time. Among its most valuable properties, which may aid to overcome special reservations related to b-blocker therapy in the acute setting, landiolol has a potent negative chronotropic effect while at the same time it exhibits a mild negative inotropic effect. This expert opinion review aims to present basic pharmacologic aspects of landiolol and provide current clinical research focused on its efficacy and safety. Landiolol is a valuable and safe pharmacologic agent in acute cardiac care. Japanese and European guidelines have incorporated its use for the management of atrial tachyarrhythmia in patients with cardiac dysfunction. Although emerging clinical trials have experimented its use in patients with sustained ventricular tachycardia/fibrillation, acute myocardial infarction undergoing primary percutaneous intervention and in patients with septic cardiomyopathy, more studies are needed in order to establish its value in such cardiac conditions. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

15. Levosimendan: Molecular mechanisms and clinical implications: Consensus of experts on the mechanisms of action of levosimendan

Author

Papp, Zoltán, Édes, István, Fruhwald, Sonja, De Hert, Stefan G., Salmenperä, Markku, Leppikangas, Heli, Mebazaa, Alexandre, Landoni, Giovanni, Grossini, Elena, Caimmi, Philippe, Morelli, Andrea, Guarracino, Fabio, Schwinger, Robert H.G., Meyer, Sven, Algotsson, Lars, Wikström, Bernt Gerhard, Jörgensen, Kirsten, Filippatos, Gerasimos, Parissis, John T., González, Martín J. García, Parkhomenko, Alexander, Yilmaz, Mehmet Birhan, Kivikko, Matti, Pollesello, Piero, and Follath, Ferenc

Published
2012
Full Text
View/download PDF

19. Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity

Author

Parissis, John T., Andreoli, Chiara, Kadoglou, Nikolaos, Ikonomidis, Ignatios, Farmakis, Dimitrios, Dimopoulou, Ioanna, Iliodromitis, Efstathios, Anastasiou-Nana, Maria, Lainscak, Mitja, Ambrosio, Giussepe, Mebazaa, Alexandre, Filippatos, Gerasimos, and Follath, Ferenc

Published
2014
Full Text
View/download PDF

22. Prognostic Value of Tissue Doppler Right Ventricular Systolic and Diastolic Function Indexes Combined With Plasma B-Type Natriuretic Peptide in Patients With Advanced Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy

Author

Bistola, Vasiliki, Parissis, John T., Paraskevaidis, Ioannis, Panou, Fotios, Nikolaou, Maria, Ikonomidis, Ignatios, Flessas, Nikolaos, Filippatos, Gerasimos, Iliodromitis, Efstathios, and Kremastinos, Dimitrios T.

Published
2010
Full Text
View/download PDF

27. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

Author

Ponikowski, Piotr, Voors, Adriaan A., Anker, Stefan D., Bueno, Héctor, Cleland, John G.F., Coats, Andrew J.S., Falk, Volkmar, González-Juanatey, José Ramón, Harjola, Veli-Pekka, Jankowska, Ewa A., Jessup, Mariell, Linde, Cecilia, Nihoyannopoulos, Petros, Parissis, John T., Pieske, Burkert, Riley, Jillian P., Rosano, Giuseppe M.C., Ruilope, Luis M., Ruschitzka, Frank, Rutten, Frans H., and van der Meer, Peter

Published
2016
Full Text
View/download PDF

28. Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica

Author

Ponikowski, Autores/Miembros del Grupo de Trabajo: Piotr, Voors, Adriaan A., Anker, Stefan D., Bueno, Héctor, Cleland, John G.F., Coats, Andrew J.S., Falk, Volkmar, González-Juanatey, José Ramón, Harjola, Veli-Pekka, Jankowska, Ewa A., Jessup, Mariell, Linde, Cecilia, Nihoyannopoulos, Petros, Parissis, John T., Pieske, Burkert, Riley, Jillian P., Rosano, Giuseppe M.C., Ruilope, Luis M., Ruschitzka, Frank, Rutten, Frans H., van der Meer, Peter, Filippatos, Revisores del documento: Gerasimos, McMurray, John J.V., Aboyans, Victor, Achenbach, Stephan, Agewall, Stefan, Al-Attar, Nawwar, James Atherton, John, Bauersachs, Johann, Camm, A. John, Carerj, Scipione, Ceconi, Claudio, Coca, Antonio, Elliott, Perry, Erol, Çetin, Ezekowitz, Justin, Fernández-Golfín, Covadonga, Fitzsimons, Donna, Guazzi, Marco, Guenoun, Maxime, Hasenfuss, Gerd, Hindricks, Gerhard, Hoes, Arno W., Iung, Bernard, Jaarsma, Tiny, Kirchhof, Paulus, Knuuti, Juhani, Kolh, Philippe, Konstantinides, Stavros, Lainscak, Mitja, Lancellotti, Patrizio, Lip, Gregory Y.H., Maisano, Francesco, Mueller, Christian, Petrie, Mark C., Piepoli, Massimo F., Priori, Silvia G., Torbicki, Adam, Tsutsui, Hiroyuki, van Veldhuisen, Dirk J., Windecker, Stephan, Yancy, Clyde, and Zamorano, José Luis

Published
2016
Full Text
View/download PDF

29. Renal Effects of Levosimendan: A Consensus Report

Author

Yilmaz, Mehmet B., Grossini, Elena, Silva Cardoso, José C., Édes, István, Fedele, Francesco, Pollesello, Piero, Kivikko, Matti, Harjola, Veli-Pekka, Hasslacher, Julia, Mebazaa, Alexandre, Morelli, Andrea, le Noble, Jos, Oldner, Anders, Oulego Erroz, Ignacio, Parissis, John T., Parkhomenko, Alexander, Poelzl, Gerhard, Rehberg, Sebastian, Ricksten, Sven-Erik, Rodríguez Fernández, Luís M., Salmenperä, Markku, Singer, Mervyn, Treskatsch, Sascha, Vrtovec, Bojan, and Wikström, Gerhard

Published
2013
Full Text
View/download PDF

34. Exhaled Breath Condensate in Acute and Chronic Heart Failure: New Insights into the Role of Lung Injury and Barrier Dysfunction

Author

Pappas, Loukas K., Giannopoulos, Georgios, Loukides, Stelios, Gavrielatos, Gerasimos, Athanasopoulou, Efrossini, Alexanian, Ioannis P., Farmakis, Dimitrios, Korovesi, Ioanna, Letsas, Konstantinos P., Parissis, John T., Deftereos, Spyridon, Pyrgakis, Vlassis N., Kotanidou, Anastasia, Kremastinos, Dimitrios T., and Filippatos, Gerasimos S.

Published
2014
Full Text
View/download PDF

48. Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy

Author

Adamopoulos, Stamatis, Parissis, John T., Georgiadis, Michael, Karatzas, Dimitrios, Paraskevaidis, John, Kroupis, Christos, Karavolias, George, Koniavitou, Katerina, and Kremastinos, Dimitrios Th.

Subjects
Heart failure -- Care and treatment, Somatotropin -- Health aspects, Cardiomyopathy, Dilated -- Care and treatment, Health
Published
2002

49. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

Author

McMurray, John J.V., Adamopoulos, Stamatis, Anker, Stefan D., Auricchio, Angelo, Böhm, Michael, Dickstein, Kenneth, Falk, Volkmar, Filippatos, Gerasimos, Fonseca, Cândida, Gomez-Sanchez, Miguel Angel, Jaarsma, Tiny, Køber, Lars, Lip, Gregory Y.H., Maggioni, Aldo Pietro, Parkhomenko, Alexander, Pieske, Burkert M., Popescu, Bogdan A., Rønnevik, Per K., Rutten, Frans H., Schwitter, Juerg, Seferovic, Petar, Stepinska, Janina, Trindade, Pedro T., Voors, Adriaan A., Zannad, Faiez, Zeiher, Andreas, Bax, Jeroen J., Baumgartner, Helmut, Ceconi, Claudio, Dean, Veronica, Deaton, Christi, Fagard, Robert, Funck-Brentano, Christian, Hasdai, David, Hoes, Arno, Kirchhof, Paulus, Knuuti, Juhani, Kolh, Philippe, McDonagh, Theresa, Moulin, Cyril, Popescu, Bogdan A., Reiner, Željko, Sechtem, Udo, Sirnes, Per Anton, Tendera, Michal, Torbicki, Adam, Vahanian, Alec, Windecker, Stephan, McDonagh, Theresa, Sechtem, Udo, Bonet, Luis Almenar, Avraamides, Panayiotis, Ben Lamin, Hisham A., Brignole, Michele, Coca, Antonio, Cowburn, Peter, Dargie, Henry, Elliott, Perry, Flachskampf, Frank Arnold, Guida, Guido Francesco, Hardman, Suzanna, Iung, Bernard, Merkely, Bela, Mueller, Christian, Nanas, John N., Nielsen, Olav Wendelboe, Ørn, Stein, Parissis, John T., and Ponikowski, Piotr

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results